Moreover, the expression level of GALK1 (the enzyme that converts galactose to galactose-1-phosphate) was shown to correlate with poor prognosis in glioblastoma [28] as well as in colorectal cancer [29]. This evidence concerns the gene GALK1 and glioblastoma.